28 Jul. 2014
WILMINGTON, N.C. (July 28, 2014) – Pharmaceutical Product Development, LLC (PPD) today announced the appointment of Henry Levy as executive vice president of client development and commercial services. Levy leads PPD’s customer-facing teams to optimize strategies and deliver results through cross-functional collaboration across the full range of clinical research services.
“With two decades of industry experience, Henry brings an impressive track record of relationship-building at the highest levels of the industry to enhance PPD’s efforts to fuel innovation and R&D success for our biopharmaceutical clients,” said David Simmons, PPD’s chairman and chief executive officer. “He is a welcome addition to PPD’s senior leadership team and shares our passion for serving clients with the industry’s most responsive, strategic and forward-thinking teams and solutions.”
Levy joined PPD from Accenture, where for the past 21 years he built a strong reputation helping biopharmaceutical clients define and deliver on high-performance strategies. Most recently, he served as global managing director of Accenture’s life sciences research and development practice. Levy’s experience also includes working with biopharmaceutical industry leaders to drive pre-competitive collaboration solutions.
Levy earned a bachelor’s degree in bioengineering from the University of Pennsylvania.
PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.
+1 919 456 5350
+1 910 558 7585